Overview & Definition
Bone Marrow Failure occurs when the bone marrow fails to produce sufficient quantities of healthy red cells, white cells, and platelets, leading to pancytopenia.
Types & Classification
- Severe Aplastic Anemia (SAA)
- Very Severe Aplastic Anemia (VSAA)
- Fanconi Anemia (Inherited)
- Pure Red Cell Aplasia (PRCA)
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
Underlying Causes & Risk Factors
- Autoimmune destruction of hematopoietic stem cells
- Toxic chemical exposure or viral infections (Hepatitis, EBV)
- Genetic telomere & DNA repair defects
Common Symptoms & Warning Signs
Diagnostic Evaluation
Accurate diagnosis requires comprehensive laboratory investigation under expert hematological supervision:
- 🔍 Complete Blood Count showing Pancytopenia
- 🔍 Reticulocyte Count & Flow Cytometry for PNH clone
- 🔍 Bone Marrow Aspiration & Biopsy showing hypocellular marrow (< 25% cellularity)
- 🔍 Chromosomal Breakage Test for Fanconi Anemia
Treatment Options & Clinical Management
- 💊 Allogeneic Hematopoietic Stem Cell Transplant – primary curative treatment for young patients with severe aplastic anemia who have a matched sibling donor.
- 💊 Triple Immunosuppressive Therapy (hATG + Cyclosporine + Eltrombopag) – standard first-line therapy for patients lacking a matched sibling donor or older adults.
- 💊 Targeted Complement Inhibitors (Eculizumab / Ravulizumab) – indicated for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) clones to prevent intravascular hemolysis and thrombosis.
- 💊 Supportive Transfusion & Antimicrobial Care – leukoreduced packed RBC and platelet transfusions alongside prophylactic anti-infectives.
Frequently Asked Questions
Early warning signs include progressive weakness, pallor, shortness of breath (from anemia), unexplained fever or frequent bacterial/fungal infections (from neutropenia), and easy bruising, nosebleeds, or petechiae (from thrombocytopenia).
Diagnosis requires a complete blood count showing pancytopenia, reticulocyte count, flow cytometry for PNH clone screening, bone marrow aspiration & trephine biopsy (demonstrating hypocellular marrow <25%), and chromosomal breakage testing for Fanconi anemia.